Rights and permissions
About this article
Cite this article
Bicalutamide as adjuvant therapy warranted in early prostate cancer. Pharmacoecon. Outcomes News 459, 9 (2004). https://doi.org/10.2165/00151234-200404590-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404590-00022